“1 new coronavirus-related death recorded on Oahu and 115 additional infections statewide - Honolulu Star-Advertiser” plus 1 more

---

1 new coronavirus-related death recorded on Oahu and 115 additional infections statewide - Honolulu Star-Advertiser Posted: 29 Jan 2021 05:11 PM PST UPDATE: 3:20 p.m. Health officials said this afternoon the latest death on Oahu was a woman in her 50s who had underlying health conditions when she was hospitalized with COVID-19. Hawaii health officials referred to CDC in defining "underlying medical conditions," such as cancer, chronic kidney disease, chronic obstructive pulmonary disease, down syndrome, heart conditions, weakened immune system from a solid organ transplant, obesity, severe obesity, pregnancy, sickle cell disease, smoking and Type 2 diabetes. According to the latest information from the department's Hawaii COVID-19 Data dashboard, a total of 75 patients with the virus were in Hawaii hospitals as of this morning, with 20 in intensive care units and 15 on ventilators. PREVIOUS COVERAGE Hawaii Department of Health officials today reported one new coronavirus-related death and 115 additional infections, bringing the state's totals since the start of the pandemic to 407 fatalities and 25,656 cases. No further details were immediately available on the latest death on Oahu. The state's official coronavirus-related death toll includes 325 fatalities on Oahu, 53 on Hawaii island, 25 on Maui, one on Kauai, and three Hawaii residents who died on the mainland. The U.S. coronavirus-related death toll was more than 434,000 today. Today's new statewide infection cases reported by the Health Department include 75 on Oahu, 24 on Maui, five on the Big Island, and 11 residents diagnosed outside of Hawaii, officials said. The statistics released today reflect the new infection cases reported to the department on Wednesday. >> RELATED STORY: Pandemic drives sharp drop in Hawaii tourism, with arrivals down 75% The total number of coronavirus cases by island since the start of the outbreak are 20,782 on Oahu, 2,144 in Hawaii County, 1,706 on Maui, 178 on Kauai, 107 on Lanai and 25 on Molokai. There are also 714 Hawaii residents diagnosed outside of the state. Health officials also said today that of the state's total infection count, 1,501 cases were considered to be active. Officials say they consider infections reported in the past 14 days to be a "proxy number for active cases." The number of active cases in the state decreased by 38 today. By island, Oahu has 1,098 active cases, Maui has 307, the Big Island has 89, Kauai has six, Lanai has one, according to the state's latest tally. Molokai has no active COVID cases. State health officials said Thursday they are investigating two separate COVID-19 clusters in Maui County with a total of nine cases involving hotel employees; two separate clusters with 18 total cases at unidentified food suppliers; two separate clusters with a total of 14 cases at unidentified restaurants; three separate clusters with 20 total cases at construction and industrial settings; and four separate clusters with 123 total cases at apartment complexes. On Oahu, health officials are investigating one large cluster with 678 total cases at correctional facilities; two separate clusters with 31 total cases at unidentified restaurants; and one cluster with 13 total cases at an unnamed residential facility. Health officials counted 15,171 new COVID-19 test results in today's tally, for a 0.76% statewide positivity rate. The state's 7-day average positivity rate is 2.5%, according to the Hawaii COVID-19 Data dashboard. Of all the confirmed Hawaii infection cases, 1,683 have required hospitalizations, with one less hospitalization reported today by state health officials. Four hospitalizations in the statewide count are Hawaii residents who were diagnosed and treated outside the state. Of the 1,679 hospitalizations within the state, 1,473 have been on Oahu, 98 on Maui, 95 on the Big Island, seven on Kauai, five on Lanai and one on Molokai. According to the latest information from the department's Hawaii COVID-19 Data dashboard, a total of 83 patients with the virus were in Hawaii hospitals as of Thursday morning, with 20 in intensive care units and 16 on ventilators. Health officials said that as of Sunday, 106,654 vaccines have been administered of the 170,975 received by the state. The administered vaccinations by county are Honolulu, 68,521; Maui, 11,060; Hawaii, 10,459 and Kauai, 8,799. The total also included several thousand administered under the federal pharmacy program. State officials release the verified updated vaccination numbers each Wednesday. Oahu moved to the less-restrictive Tier 2 of Honolulu's four-tier economic recovery plan on Oct. 22. To gauge whether Honolulu will move to a different tier, the city takes a "weekly assessment" of two key COVID-19 numbers each Wednesday. To move to Tier 3 from Tier 2, the 7-day average of new cases must be below 50 on two consecutive Wednesdays. Also, the 7-day average positivity rate must be below 2.5% on those two Wednesdays. Today's seven-day average case count for Oahu is 79 and the seven-day average positivity rate is 2.9%, according to Honolulu Mayor Rick Blangiardi. Blangiardi has said he hoped to stay in Tier 2, a four-tiered framework established by former Mayor Kirk Caldwell. Under Tier 3, social gatherings of up to 10 would be allowed, up from 5 under Tier 2, and retail businesses would be able to operate at full capacity, rather than 50% capacity under Tier 2. This breaking news story will be updated as more information becomes available.

NeuTigers Launches CovidDeep, A Rapid Screening App Using Wearable Sensor Data to Detect COVID-19 Infection - Food & Beverage Magazine - Food & Beverage Magazine Posted: 12 Jan 2021 12:00 AM PST NeuTigers, an Artificial Intelligence company spun out of Princeton University, today launched CovidDeep, a clinically validated solution that can triage those needing further testing for SARS-CoV-2/COVID-19 using physiological sensors data derived from wearable devices. The CovidDeep app is 90%+ accurate in predicting whether a person is virus-free or virus-positive, and is twice as effective as current triage tools, such as temperature checks and questionnaires. Early in the pandemic, NeuTigers realized its StarDeep™ Smart Healthcare Platform, which delivers AI-powered solutions to augment healthcare professionals' productivity, could be used in the fight against COVID-19. CovidDeep was developed through rigorous clinical research and validation trials beginning at San Matteo Hospital in Pavia, Italy, during the acute phase of the COVID-19 pandemic in April 2020, with further expanded prospective field studies in hospitals in France and the United States to explore its robustness. A powerful tool for businesses and healthcare facilities who regularly screen for COVID-19, CovidDeep is already deployed in B2B settings including multiple nursing homes and assisted living facilities in America and Europe. Designed to help keep work and medical facilities safe, CovidDeep is effective in multiple industries and use cases, and today is being made widely available. CovidDeep works by collecting physiological sensor data from the Empatica E4 wristband, blood pressure and blood oxygen levels from any off-the-shelf, standalone monitors as well as personal health symptoms from a brief questionnaire. As a potential game-changer in the rapid and cost-effective screening of SARS-CoV-2/COVID-19, it is already being adapted to work with connected health products from Fitbit, Withings, Apple, Samsung, and other devices. The CovidDeep consumer app is expected in early 2021. Deep Neural Networks COVID-19 affects people's biometrics and physiological markers in both obvious and nearly imperceptible ways. Using advanced algorithms of machine learning, CovidDeep is so sensitive it can detect changes in these physiological patterns even before they are felt by the patient and all with real-time analysis. CovidDeep is powered by cutting-edge AI deep neural networks that mimic how the human brain perceives, learns, and interprets the world. NeuTigers' research co-founders at the Department of Electrical Engineering at Princeton University used proprietary deep neural networks to learn from hundreds-of-thousands of digital health data points and a specific questionnaire in SARS-CoV-2-positive and healthy participants. They identified patterns in the sensor physiological readings such as Galvanic Skin Response (GSR), Skin temperature, Heart Inter-beat Interval (IBI), Blood pressure, and Blood oxygen saturation levels (SpO2) that are consistent with how COVID-19 impacts the body. CovidDeep can recognize the 'digital signature' of SARS-CoV-2/COVID-19 and quickly identify if a person is COVID-positive, even if they do not have symptoms (asymptomatic). CovidDeep is shown from the controlled clinical study at San Matteo hospital to predict SARS-CoV-2/COVID-19 with upwards of 90% accuracy, almost twice as effective as temperature checks and visual symptoms checks, which NeuTiger's study and others have shown predict COVID-19 with around 50% accuracy. "Advances in machine learning and the proliferation of medical-grade sensors in everyday consumer wearables has led to a new era in which we can predict and identify the onset of a myriad of diseases," said Adel Laoui, CEO and founder of NeuTigers. "Before the pandemic, our teams were using predictive models in our StarDeep health platform to monitor and screen for diabetes and mental health conditions." "Realizing our AI technology could be valuable in the fight against COVID-19, we quickly pivoted and developed a new solution after rigorous clinical research trials. Initially meeting the urgent need for mass screening in the business environment, CovidDeep is set to expand to a wider consumer offering in early 2021," he continued. CovidDeep – How it Works CovidDeep brings forth groundbreaking science as an app that can predict SARS CoV-2/COVID-19 accurately, safely, quickly, and importantly by preserving people's privacy. Users simply answer a questionnaire regarding symptoms and health history (based on CDC guidelines) and input their health sensor's data. Data is entered by connecting CovidDeep to an Empatica E4 Wristband as well as inputting blood pressure and blood oxygen readings using any off-the-shelf device. All data remains local to the device, is never shared, and stays securely and privately under the user's control. CovidDeep then analyzes the data and provides a prediction as to whether someone is likely to be negative or positive for SARS CoV-2/COVID-19. The process takes around 2 minutes, allowing one Empatica device, blood pressure monitor and pulse oximeter to screen unlimited numbers of people after being sanitized between usages. Available globally from January 12, 2021, on Android with iOS availability coming soon, users can try CovidDeep for free with unlimited screening results for seven days. Combatting COVID – Today and Tomorrow CovidDeep represents a critical tool in combating SARS-CoV-2/COVID-19 both today and in the future. Public health professionals and policymakers agree that rapid and mass testing is the key to controlling the spread of the virus and reopening society and the economy. CovidDeep is a powerful bridge to affordable mass testing and a highly scalable solution to efficiently triage scarce medical resources worldwide. "Whether helping frontline healthcare workers, employers keeping the workplace safe, assisting airlines in reestablishing consumer confidence in travel, helping students to stay in schools, or providing fast access to sporting and entertainment venues, the applications of CovidDeep are endless," added Laoui. NeuTigers is continuing extended clinical field testing worldwide to further hone the app's accuracy to ensure that no geographic, demographic, or ethnic biases occur. In addition to completed trials in Italy, validation field-testing studies are currently ongoing in the United States, France and planned in North Africa, Switzerland, Japan, and India. For further information on CovidDeep, please visit www.neutigers.com/coviddeep. Like this: Like Loading...

You are subscribed to email updates from "infection app" - Google News. To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States